|
Antibiotics
|
| Global Industry Analyst | 786 pages | Juillet 2007 | Anglais
| |
This report analyzes the worldwide markets for Antibiotics in US$ Billion.
The Major product segments Analyzed are Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and Other Antibio ... |
3.160,00 € |
| |
| |
|
|
| |
|
|
Monoclonal Antibodies Report Market Model
|
| Datamonitor | 50 pages | Juin 2007 | Anglais
| |
| IntroductionThe model provides a comprehensive analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing trends by product, company, therapy area, technology and targe ... |
6.080,00 € |
| |
| |
|
|
| |
|
|
Global Tuberculosis Strategies
|
| Kalorama Information | 250 pages | Juin 2007 | Anglais
| |
The importance, danger and costs of tuberculosis in the 21st century cannot be understated or underestimated.
Though nearly extinct in the 20th century, over 1.6 billion people worldwide suffer fro ... |
3.196,00 € |
| |
| |
|
|
| |
|
|
|
|
|
|
Autoimmune Market Outlook to 2012
|
| Business Insight | 216 pages | Août 2007 | Anglais
| |
Autoimmune related disorders continue to maintain prominence within the global disease burden, having achieved a worldwide market growth of 9.4% over the 2002-06 period.
However, the inherent threa ... |
2.300,00 € |
| |
| |
|
|
| |
|
|
|
|
|
|
Global Hepatitis Strategies
|
| Kalorama Information | 200 pages | Août 2007 | Anglais
| |
The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated.
While we were fortunate that, in the latter part of the 20th century, in that ... |
3.196,00 € |
| |
| |
|
|
| |
|
|
|
